News – Page 1064 – Endpoints News

Made in China: TaiMed wins FDA OK for a 'breakthrough' HIV therapy for drug-resistant patients

8 years ago

Jakobovits abruptly exits Adicet; Stanford researchers uncover mechanistic details of ALS using CRISPR

8 years ago

Faster, more convenient Opdivo dosing schedules gives Bristol-Myers added edge in battle of the PD-1 blockbusters ...

8 years ago

ViewPoint Therapeutics gets $35M to advance non-surgical alternative for cataracts, presbyopia

8 years ago

After bagging Shire’s cell therapy castoff, Caladrius stock climbs

8 years ago

Searching for HIV cure, Gilead's new 'shock and kill' combo swats back lethal virus in monkeys

8 years ago

Quiet and confidential IPO registration? Who needs it. Autolus shouts about its next big raise

8 years ago

Cambridge star Magenta teams up with Heidelberg on bone marrow R&D pact that includes $334M in potential milestones

8 years ago

Judgment day is coming: Federal judge orders Martin Shkreli to forfeit a small fortune following felony convictions

8 years ago

Global CRO Parexel woos outsourcing veteran Jamie Macdonald to the helm

8 years ago

Arcus to raise $99M IPO; Vanda wants marketing approval for jet lag

8 years ago

Stock flies high on Clearside’s PhIII macular edema trial results as drug improves vision

8 years ago

Chinese medicine player Tasly considers Hong Kong IPO for its biotech arm: report

8 years ago

Watch out below: Dermira axes acne drug after a catastrophic PhIII failure

8 years ago

Santhera’s Raxone fails NIH’s MS study in latest setback, shares plunge

8 years ago

Gene editing expert Homology details the numbers in its back-ended $1B Novartis deal, files for $100M IPO

8 years ago

Is tech money bad for business? Silicon Valley cash makes some biopharma VCs bristle, others cheer

8 years ago

Celgene hands over $101M in cash to launch a research collaboration with protein player Vividion

8 years ago

Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold

8 years ago

EpimAb nabs Bin Peng from NIBR; Jeffrey Chodakewitz exits Vertex; Christiana Stamoulis is president at Unum

8 years ago

Activist investor Alex Denner in the spotlight again as the Medicines Company shrinks its board

8 years ago

Perlara collaborates with Harvard/Undiagnosed Diseases Network; Verona shares soar on positive CF data

8 years ago

Amid a boisterous fundraising week, BioMedPartners airs $107M biotech fund

8 years ago

Asian investor commits $15M to launch new protein degradation biotech startup Cullgen out of UNC

8 years ago

First page Previous page 1061 1062 106310641065 1066 1067 Next page Last page